Results
1 -
10 of
97Sean Ekins, Justin Bradford, Krishna Dole, Anna Spektor, Kellan Gregory, David Blondeau, Moses Hohman and Barry A. Bunin.
A collaborative database and computational models for tuberculosis drug discovery, Mol. Biosyst., 2010, 6, 840. Guo-Yi Bai, Chen-Fang Zhang, Yue-Cheng Zhang, Tao Zeng and Jiang-Sheng Li .
(S,S)-2,2'-(1,2-Ethanediyldiimino)dibutan-1-ol. Corrigendum , Acta Cryst (2007). E63, e2-e3 Â Â Yangzhe Wu and Anhong Zhou.
In situ, real-time tracking of cell wall topography and nanomechanics of antimycobacterial drugs treated Mycobacterium JLS using atomic force microscopy, Chem. Commun., 2009, 7021. Meenakshi Anurag and Debasis Dash.
Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis, Mol. Biosyst., 2009, 5, 1752. Claire Verbelen and Yves F. Dufrêne.
Direct measurement of Mycobacterium–fibronectin interactions, Integr. Biol., 2009, 1, 296. Stephen Michael Rajesh, Subbu Perumal, J. Carlos Menéndez, Perumal Yogeeswari and Dharmarajan Sriram.
Antimycobacterial activity of spirooxindolo-pyrrolidine, pyrrolizine and pyrrolothiazole hybrids obtained by a three-component regio- and stereoselective 1,3-dipolar cycloaddition, Med. Chem. Commun., 2011, 2, 626. Samala Ganesh, Devi Parthiban Brindha, Nallangi Radhika, Sridevi Jonnalagadda Padma, Saxena Shalini, Yogeeswari Perumal, Sriram Dharmarajan.
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: Molecular hybridization from known antimycobacterial leads, Bioorganic & Medicinal Chemistry, 2014 Organization of the mycobacterial cell wall: a nanoscale view, Pfl??gers Archiv - European Journal of Physiology New trends in the chemotherapy of tuberculosis u2014 Current aspects, Pneumonologie Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period, Journal of Infection and Chemotherapy